Identification and functional analysis of SKA2 interaction with the glucocorticoid receptor

Journal of Endocrinology

Volumn 198, Issue 3, 2008, Pages 499-509

  Rice, Lisa ^a   Waters, Charlotte E ^a   Eccles, Jennifer ^a   Garside, Helen ^a   Sommer, Paula ^a   Kay, Paul ^a   Blackhall, Fiona H ^a   Zeef, Leo ^a   Telfer, Brian ^b   Stratford, Ian ^b   Clarke, Rob ^a   Singh, Dave ^a   Stevens, Adam ^a   White, Anne ^a   Ray, David W ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; DEXAMETHASONE; GENE PRODUCT; GLUCOCORTICOID RECEPTOR; PHORBOL ESTER; PROTEIN FAM33A; PROTEIN SKA2; SHORT HAIRPIN RNA; SOMATOMEDIN C; STAUROSPORINE; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CELL PROLIFERATION; CELL STRAIN HEPG2; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; HELA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INHIBITION KINETICS; LUNG ALVEOLUS EPITHELIUM; LUNG SMALL CELL CANCER; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TUMOR XENOGRAFT; WESTERN BLOTTING;

3T3-L1 CELLS; AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMOSOMAL PROTEINS, NON-HISTONE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MICE; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN BINDING; RECEPTORS, GLUCOCORTICOID; RNA, SMALL INTERFERING; SEQUENCE HOMOLOGY, AMINO ACID; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 53349171624     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0019     Document Type: Article

References (34)

1. Alourfi Z, Donn RP, Stevens A, Berry A, McMaster A & Ray DW 2005 Glucocorticoids suppress macrophage migration inhibitory factor (MIF) expression in a cell-type-specific manner. Journal of Molecular Endocrinology 34 583-595.
2. Baillie-Johnson H, Twentyman PR, Fox NE, Walls GA, Workman P, Watson JV, Johnson N, Reeve JG & Bleehen NM 1985 Establishment and characterisation of cell lines from patients with lung cancer (predominantly small cell carcinoma). British Journal of Cancer 52 495-504.
3. Bolstad BM, Irizarry RA, Astrand M & Speed TP 2003 A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19 185-193.
4. Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM & Mangelsdorf DJ 2006 Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126 789-799.
5. Cheskis BJ, McKenna NJ, Wong CW, Wong J, Komm B, Lyttle CR & O'Malley BW 2003 Hierarchical affinities and a bipartite interaction model for estrogen receptor isoforms and full-length steroid receptor coactivator (SRC/p160) family members. Journal of Biological Chemistry 278 13271-13277.
6. Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC & Conklin BR 2003 MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biology 4 R7.
7. Garside H, Stevens A, Farrow S, Normand C, Houle B, Berry A, Maschera B & Ray D 2004 Glucocorticoid ligands specify different interactions with NF-kappaB by allosteric effects on the glucocorticoid receptor DNA binding domain. Journal of Biological Chemistry 279 50050-50059.
8. Garside H, Waters C, Berry A, Rice L, Ardley HC, White A, Robinson PA & Ray D 2006 UbcH7 interacts with the glucocorticoid receptor and mediates receptor autoregulation, Journal of Endocrinology 190 621-629.
9. Gottlicher M, Heck S & Herrlich P 1998 Transcriptional cross-talk, the second mode of steroid hormone receptor action. Journal of Molecular Medicine 76 480-489.
10. Hanisch A, Sillje HH & Nigg EA 2006 Timely anaphase onset requires a novel spindle and kinetochore complex comprising Ska1 and Ska2. EMBO Journal 25 5504-5515.
11. Hofmann J, Kaiser U, Maasberg M & Havemann K 1995 Glucocorticoid receptors and growth inhibitory effects of dexamethasone in human lung cancer cell lines. European Journal of Cancer 31A 2053-2058.
12. Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG & Evans RM 1985 Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318 635-641.
13. Iniguez-Lluhi JA, Lou DY & Yamamoto KR 1997 Three amino acid substitutions selectively disrupt the activation but not the repression function of the glucocorticoid receptor N terminus. Journal of Biological Chemistry 272 4149-4156.
14. Kassel O, Schneider S, Heilbock C, Litfin M, Gottlicher M & Herrhch P 2004 A nuclear isoform of the focal adhesion LIM-domain protein Trip6 integrates activating and repressing signals at AP-1- and NF-kappaB-regulated promoters. Genes and Development 18 2518-2528.
15. Li C & Wong WH 2001 Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. PNAS 98 31-36.
16. Lonard DM, Tsai SY & O'Malley BW 2004 Selective estrogen receptor modulators 4-hydroxytamoxifen and raloxifene impact the stability and function of SRC-1 and SRC-3 coactivator proteins. Molecular and Cellular Biology 24 14-24.
17. Margolis RN, Evans RM & O'Malley BW 2005 The Nuclear Receptor Signaling Atlas: development of a functional atlas of nuclear receptors. Molecular Endocrinology 19 2433-2436.
18. Nissen RM & Yamamoto KR 2000 The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes and Development 14 2314-2329.
19. O'Malley BW 2004 Results ofa search for the mechanisms of steroid receptor regulation of gene expression. Annals of the New York Academy of Sciences 1038 80-87.
20. Perlmann T & Evans RM 1997 Nuclear receptors in Sicily: all in the famiglia. Cell 90 391-397.
21. Pettengill OS, Sorenson GD, Wurster-Hill DH, Curphey TJ, Noll WW, Cate CC & Maurer LH 1980 Isolation and growth characteristics of continuous cell lines from small-cell carcinoma of the lung. Cancer 45 906-918.
22. Ray DW, Littlewood AC, Clark AJ, Davis JR & White A 1994 Human small cell lung cancer cell lines expressing the proopiomelanocortin gene have aberrant glucocorticoid receptor function. Journal of Clinical Investigation 93 1625-1630.
23. Ray DW, Davis JR, White A & Clark AJ 1996a Glucocorticoid receptor structure and function in glucocorticoid-resistant small cell lung carcinoma cells. Cancer Research 56 3276-3280.
24. Ray DW, Ren SG & Melined S 1996b Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway. Journal of Clinical Investigation 97 1852-1859.
25. Ray DW, Suen CS, Brass A, Soden J & White A 1999 Structure/function of the human glucocorticoid receptor: tyrosine 735 is important for transactivation. Molecular Endocrinology 13 1855-1863.
26. Smyth GK 2004 Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Statistical Applications in Genetics and Molecular Biology 3 Article3.
27. Sommer P, Le Rouzic P, Gillingham H, Berry A, Kayahara M, Huynh T, White A & Ray DW 2007 Glucocorticoid receptor overexpression exerts an antisurvival effect on human small cell lung cancer cells. Oncogene 26 7111-7121.
28. Stevens A, Garside H, Berry A, Waters C, White A & Ray D 2003 Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735. Molecular Endocrinology 17 845-859.
29. Storey JD, Taylor JE & Siegmund D 2004 Strong control, conservative point estimation, and simultaneous conservative consistency of false discovery rates: a unified approach. Journal of the Royal Statistical Society. Series B 66 187-205.
30. Weinberger C. Hollenberg SM, Ong ES, Harmon JM, Brower ST, Cidlowski J, Thompson EB, Rosenfeld MG & Evans RM 1985 Identification of human glucocorticoid receptor complementary DNA clones by epitope selection. Science 228 740-742.
31. Weinberger C, Giguere V, Hollenberg SM, Thompson C, Arriza J & Evans RM 1987 Human steroid receptors and erb-A gene products form a superfamily of enhancer-binding proteins. Clinical Physiology and Biochemistry 5 179-189.
32. Witschi H, Espiritu I, Ly M & Uyeminami D 2005 The chemopreventive effects of orally administered dexamethasone in Strain A/J mice following cessation of smoke exposure. Inhalation Toxicology 17 119-122.
33. Wu HY, Hamamori Y, Xu J, Chang SC, Saluna T, Chang MF, O'Malley BW & Kedes L 2005 Nuclear hormone receptor coregulator GRIP1 suppresses, whereas SRC1A and p/CIP coactivate, by domain-specific binding of MyoD. Journal of Biological Chemistry 280 3129-3137.
34. Zhu Y, Singh B, Hewitt S, Liu A, Gomez B, Wang A & Clarke R 2006 Expression patterns among interferon regulatory factor-1, human X-box binding procein-1, nuclear factor kappa B, nucleophosmin, estrogen receptor-alpha and progesterone receptor proteins in breast cancer tissue microarrays. International Journal of Ontology 28 67-76.